Navigation Links
Blueberry-Supplemented Diet Shows Promise in Lowering Cholesterol in Animal Trials
Date:6/19/2008

PORTLAND, Maine, June 19 /PRNewswire/ -- New research published in the British Journal of Nutrition (Br J Nutr., Dec. 17, PMID: 18081945, 2007) shows that blueberries may have a cardio-protective effect, by significantly lowering cholesterol. Lead scientist, Wilhelmina Kalt, Ph.D, from Agriculture and Agri-Food Canada conducted tests on pigs fed a blueberry-supplemented diet. Blueberry-supplemented diets resulted in a reduction in total cholesterol including both LDL and HDL levels. The greatest reduction in total, LDL and HDL cholesterol levels was found in pigs fed a 2% blueberry diet equivalent to approximately 2 one-cup servings of blueberries in the human diet. According to the study, this could be "...reasonably achieved in the adult human diet and suggests that the observed effect from blueberry supplementation could occur in healthy humans."

"In feeding trials, we found that blueberry supplementation reduced plasma cholesterol levels more effectively when the animals received a mostly plant-based diet than when they received a less heart-healthy diet," said Dr. Kalt. "The soy, oats and barley contained in these diets may have functioned synergistically with the blueberries to beneficially affect plasma lipids."

According to Kalt, pigs were selected for study because they have levels of LDL similar to humans and are susceptible to diet-induced vascular disease. Pigs can also develop atherosclerotic plaques in the aorta and carotid artery, and have a similar blood pressure and heart rate as humans.

The Antioxidant Power of Blueberries

The antioxidant activity of blueberries may help to explain their potential cardio-protective effect observed in this study. Antioxidants are free-radical quenchers, helping protect us against cellular oxidative damage that can lead to heart disease, degenerating brain function such as in Alzheimer's disease and some types of cancer. In a comprehensive study of the antioxidant capacity of foods,
'/>"/>

SOURCE The Wild Blueberry Association of North America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
2. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
3. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
4. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
5. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
6. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
7. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
8. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
9. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
10. Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
11. CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...sciencesCorporationannouncedtodaythattherewillbemu...erationFLT3inhibitor,inAMLatthe51stAmericanSociety...,LA,December5-8,2009.Anoralpresentationwillhighlig...etystudyinadultswithacutemyeloidleukemia(AML).Addi...theeffectofAC220monotherapyandincombinationwithche...
(Date:11/24/2009)...tCall/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECT...MSystemasanon-invasive,wireless,transdermalcontinu...kinPrepSystemfortransdermaldrugdelivery,announcedt...tiveOfficer,willpresentatthe13thAnnualBiotechandSp...YorkSocietyofSecuritiesAnalysts,at2:05onDecember1,...
(Date:11/24/2009)...CardiovascularLLC,aleadingproviderofcardiovascular...eedtwo-yearcontractwithNovation,oneofthenation,sla...eproviderofsurgicaldevicesforbeatingheartcardiacsu...throughOctober31,2012,MAQUETCardiovascularwillbeth...lesuppliestothemembersofVHAInc.andUniversityHealth...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Bioniche Pharma Acquires Duraclon 28R 29 28clonidine hydrochloride injection 29 and Methadone Hydrochloride Injection USP 61269 1Bioniche Pharma Acquires Duraclon 28R 29 28clonidine hydrochloride injection 29 and Methadone Hydrochloride Injection USP 61269 2BioMS Medical Announces Third Quarter 2009 Results 14817 1BioMS Medical Announces Third Quarter 2009 Results 14817 2BioMS Medical Announces Third Quarter 2009 Results 14817 3BioMS Medical Announces Third Quarter 2009 Results 14817 4BioMS Medical Announces Third Quarter 2009 Results 14817 5BioMS Medical Announces Third Quarter 2009 Results 14817 6BioMS Medical Announces Third Quarter 2009 Results 14817 7BioMS Medical Announces Third Quarter 2009 Results 14817 8EF Johnson Technologies Announces Third Quarter Results 6230 1EF Johnson Technologies Announces Third Quarter Results 6230 2EF Johnson Technologies Announces Third Quarter Results 6230 3EF Johnson Technologies Announces Third Quarter Results 6230 4EF Johnson Technologies Announces Third Quarter Results 6230 5EF Johnson Technologies Announces Third Quarter Results 6230 6EF Johnson Technologies Announces Third Quarter Results 6230 7EF Johnson Technologies Announces Third Quarter Results 6230 8
(Date:11/24/2009)... Physician recruiting firm LocumTe...n staffing, is pleased to announce its agreement w...ovide physicians for locum tenens assignments. , ...ember 24, 2009 -- Physician recruiting firm Loc...sician staffing, is pleased to announce its agreem...
(Date:11/24/2009)...T.CLEMENS,Mich.,Nov.24/PRNewswire/--Mostpeoplelook...gdinner,gettingtogetherwithfriendsandfamily.TheMac...mily,shealthduringtheholidays.Travelingandbeinginl...berthesestepstostayhealthy: ,, VACCINATION ,...gh-riskcategoriestogetvaccinatedagainsttheH1N1stra...
(Date:11/24/2009)...ANTACLARA,Calif.,Nov.24/PRNewswire/--AgitoNetworks...erprisemobility,todayannouncedthatitwashonoredinth...AgitoRoamAnywhereMobilityRouterv3.0.EverythingChan...thathaveintroducednewsolutionsthatdriveadvancesthr...el,sTestCenterreviewedhundredsofapplicationsforthe...
(Date:11/24/2009)...HEATON,Ill.,Nov.24/PRNewswire-USNewswire/--Dr.Nels...asbeennamedtherecipientoftheJamesBradyAward.Theawa...)ofIllinoisduringtheirannualconferenceonOctober30,...wasgiventheawardinrecognitionofhisexpertiseinaddre...compassionatetreatmentandexceptionalcareofhispatie...
(Date:11/24/2009)...IRMINGHAM,Ala.,Nov.24/PRNewswire-FirstCall/--Healt...articipateintheBankofAmericaMerrillLynch2009Credit...thSeniorVicePresidentandTreasurerEdFaywillbespeaki...onwillbewebcastliveandwillbeavailableat http://inv... ,, AboutHealthSouth ,, HealthSouthisthena...
Breaking Medicine News(10 mins):Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3Health News:Marianjoy Medical Group Physician Receives James Brady Award 2
...d (ASX: TEO), a global healthcare company, announc...pheral IV catheter it is developing with Vascular ...Science Invention Award. , "Telesso is pleased to...Stacks. "Attempts to start an IV frequently fail, ...
...discussion about trade-offs , , STANFORD, Calif.,... about the trade-offs involved in health care refo...anford Center on Longevity (SCL). , , The finding...the public. , , "As lawmakers are preparing large...
... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced...nk 34th Annual Health Care Conference in Boston, M...n Time. , , A live webcast of the presentation ca...erence. , , About the Company , Founded in 1927...
... Johnson & Johnson (NYSE: JNJ ) will partici...Conference on Tuesday, May 19th, at the InterConti...wide Chairman, Pharmaceuticals Group for Johnson &...stors and parties by accessing the Johnson & J...
...cs, Inc. announces that it has enrolled its 1,000t...AS ( G auging R esponsiveness with A V erifyNow(... The trial is specifically designed to demonstrate...ebo controlled trial will determine whether tailor...
..., May 13 /PRNewswire-Asia-FirstCall/ -- Shengtai,P...hengtai" or "the Company"),a leading manufacturer ...ade,glucose products in China, today announced tha... will conduct a conference call,on Friday, May 15,...
Other Medicine News:Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 2Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 3
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: